Oct 10, 2026
ADA governance evaluation town hall gathers feedback from more than 600 attendees
More than 600 stakeholders came together to discuss the ADA governance and organizational health evaluation during a town hall Oct. 9. Read More
Oct 10, 2026
More than 600 stakeholders came together to discuss the ADA governance and organizational health evaluation during a town hall Oct. 9. Read More
Oct 9, 2026
New survey findings found that most HSA/FSA holders would use those funds to buy over-the-counter oral care products if they were eligible. Read More
Oct 9, 2026
Millions of healthcare workers now have a safer, confidential path to accessing mental health and substance use disorder care. Read More
Oct 8, 2026
The ADA 2026 Scientific Session kicked off Oct. 8 with the Science Into Practice Fireside Chat. Read More
Oct 8, 2026
Leaders from the ADA and ADA Foundation gathered with other Scientific Session attendees to pack 500 health and comfort kits for veterans. Read More
Oct 5, 2026
Three research reports related to the ADA’s governance and organizational health evaluation are available on the ADA website. Read More
Oct 5, 2026
Understanding the healthy oral virome could clarify how oral health is connected to whole-body health. Read More
Oct 5, 2026
This work builds on the organizations’ agreement from earlier this year to incorporate the DLOSCE into the ADEX Dental Examination. Read More
Oct 2, 2026
Dentists may have trouble accessing flumazenil because of an ongoing shortage. Read More
Oct 2, 2026
The ADA's Health Policy Institute supported the CDA's advocacy efforts to protect Proposition 56 funding for Medi-Cal Dental. Read More
Oct 1, 2026
The FDA is warning consumers about the risks of using unauthorized direct-to-consumer clear aligners without the supervision of a dentist. Read More
Sep 30, 2026
BCPay+ connects directly with Open Dental to bring payment activity and practice management workflows together. Read More
Sep 30, 2026
The ADA is urging the Senate Finance Committee to ensure dental benefits are included in potential health insurance reforms. Read More
Sep 30, 2026
After accomplishing its primary goals, the Coalition for Modernizing Dental Licensure disbanded in September. Read More
Sep 30, 2026
Parties have until Nov. 13 to comment on the request to be recognized as the national certifying board for oral and maxillofacial radiology. Read More
Sep 30, 2026
Parties have until Nov. 13 to comment on the request to be recognized as the national certifying board for oral and maxillofacial radiology. Read More
Sep 28, 2026
Clinical oral exams are critical to the early detection of oral cancer while biopsies remain the gold standard for definitive diagnosis. Read More
Sep 28, 2026
Many dentists and staff members are surprised the first time a payment is reduced because of an issue involving a different patient. Read More
Sep 25, 2026
Although the updated CDC guidance excludes dentists, the ADA says there are takeaways that may be useful for developing employee policies. Read More
Sep 24, 2026
The ADA is launching a cone-beam computed tomography training program with learning options for both dentists and team members. Read More
This past legislative session, the Illinois Department of Human Services introduced legislation expanding requirements for providers who use the Illinois Prescription Monitoring Program (ILPMP). The initial proposal would have required providers to check the system for every Schedule II-IV prescription rather than only the initial prescription. ISDS joined a coalition of provider organizations working with the Illinois State Medical Society to address concerns about the proposal and its potential administrative impact on providers.
The legislation was changed to address providers' concerns. As passed and signed into law, the legislation requires prescribers to document an attempt to access patient information in the ILPMP to assess patient access to controlled substances when providing an initial prescription for any Schedule II stimulant substances. It further requires providers to check the PMP for all prescriptions of Schedule II opioids and Schedule IV benzodiazepines.
Additionally, it prohibits criminal charges and disciplinary action against prescribers who fail to register for the ILPMP due to technological or electrical failures or operational issues that prevent registration.